News for Jazz Pharmaceuticals plc (JAZZN.MX)

Morgan Stanley has adjusted its price target for Jazz Pharmaceuticals (JAZZ), bringing it down from $183 to $166. Despite this adjustment, the bank maintains an

PR NewswireDUBLIN, May 6, 2025 ”“ Total revenues of $898 million in 1Q25 ”“”“ Xywav® and Epidiolex® revenues grew 9% and 10% year-over-year, respectiv

PR NewswireDUBLIN, April 30, 2025 DUBLIN, April 30, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will part

Summary Jazz Pharmaceuticals PLC (JAZZ) announced on April 25, 2025, that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Ag

PR NewswireDUBLIN, April 25, 2025 DUBLIN, April 25, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Committee for Med

Jazz Pharmaceuticals (JAZZ) has received a significant endorsement from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP). T

Summary Jazz Pharmaceuticals PLC (JAZZ) announced on April 23, 2025, that it will present seven abstracts at the American Society of Clinical Oncology (ASCO) An

PR NewswireDUBLIN, April 23, 2025 Statistically significant and clinically meaningful progression-free survival (PFS) and overall survival (OS) data for Ze

Summary Jazz Pharmaceuticals PLC (JAZZ), a leading global biopharmaceutical company, has announced that it will release its financial results for the first quar

PR NewswireDUBLIN, April 22, 2025 DUBLIN, April 22, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 20

Jazz Pharmaceuticals (JAZZ) to announce Q1 2025 financial results on May 6, 2025. Live audio webcast scheduled at 4:30 p.m. ET for financial discussion

Key Takeaways: The pharmaceutical sector is bracing for potential impacts from new U.S. tariffs. Jazz Pharmaceuticals (JAZZ) could see a significant upsi

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at where Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands against the other best mid cap biotech stocks to buy. Is the Biotech Sector Oversaturated? On March 6, Jared Holz, Mizuho health care […]

On March 19, 2025, EcoR1 Capital, LLC (Trades, Portfolio) executed a notable transaction by acquiring an additional 228,463 shares of Zymeworks Inc at a trade p

On March 13, 2025, EcoR1 Capital, LLC (Trades, Portfolio), a prominent investment firm, made a significant move by acquiring an additional 1,081,980 shares of Z

PR NewswireNEW YORK, March 17, 2025 NEW YORK, March 17, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations

PR NewswireNEW YORK, March 11, 2025 NEW YORK, March 11, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following

NEW YORK, March 08, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations